Stockreport

Akers Biosciences up 25% on in-license of coronavirus vaccine candidate [Seeking Alpha]

AKERS BIOSCIENCES INC COMMON S  (AKER) 
US:NASDAQ Investor Relations: akersbio.com/investor-center
PDF Healthcare | On the Move Akers Biosciences up 25% on in-license of coronavirus vaccine candidate Mar. 24, 2020 10:39 AM ET Akers Biosciences, Inc. (AKER) Douglas W. Hous [Read more]